HSP90B1 and breast carcinoma: For instance, sXBP1 has no correlation with tumor size in breast cancer [36], while the increased expression of BiP and GRP94 was correlated with a larger tumor size and enhanced metastatic capability in esophageal adenocarcinomas [37].